All About Multiple Sclerosis

More MS news articles for May 2004

Taxol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-kappaB.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15141302

Cell Mol Life Sci. 2004 May;61(10):1167-75
Cvetkovic I, Miljkovic D, Vuckovic O, Harhaji L, Nikolic Z, Trajkovic V, Mostarica Stojkovic M.
Laboratory for Immunology, Institute for Biological Research 'Sinisa Stankovic', 29. Novembra 142, 11000, Belgrade, Serbia and Montenegro

Taxol is a microtubule-stabilizing agent that has recently been shown effective in the treatment of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.

As astrocytes could modulate central nervous system (CNS) autoimmunity through inducible nitric oxide synthase (iNOS)-mediated production of immunoregulatory free radical nitric oxide (NO), we investigated the effect of taxol on NO synthesis in rat astrocytes.

Taxol, either alone or in combination with interferon-gamma, induced NO generation in primary astrocytes and astrocytoma C6 cells in a dose- and time-dependent manner.

Accordingly, the drug markedly up-regulated the expression of both iNOS mRNA and protein in astrocytes.

The observed effect of taxol was mediated through induction of iNOS transcription factors NF-kappaB and IRF-1, and required the activation of p38 MAP kinase and JNK.

Finally, NO release by taxol-stimulated astrocytes was blocked with the microtubule-depolymerizing agent colchicine, suggesting the involvement of a microtubule-stabilizing activity of taxol in the observed effect.